Older patients at high risk of GI adverse effects may benefit from concomitant use of cytoprotective drugs (usually, a proton pump inhibitor; occasionally, the prostaglandin misoprostol) or substitution of a selective COX-2 inhibitor (coxib; eg, celecoxib).